ALK and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC), multiple nonhistone proteins are modified by SMYD2 mediated methylation, and effects on tumors are generated by the modified activity of signaling pathways, for example, MAPKAPK3 in PDAC and ALK [62].